LakeShore Biopharma Statistics
Total Valuation
LSB has a market cap or net worth of $30.60 million. The enterprise value is $84.80 million.
Important Dates
The next estimated earnings date is Tuesday, August 19, 2025, after market close.
| Earnings Date | Aug 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LSB has 41.21 million shares outstanding. The number of shares has increased by 89.95% in one year.
| Current Share Class | 41.21M |
| Shares Outstanding | 41.21M |
| Shares Change (YoY) | +89.95% |
| Shares Change (QoQ) | +59.60% |
| Owned by Insiders (%) | 87.63% |
| Owned by Institutions (%) | 2.13% |
| Float | 4.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.17 |
| Forward PS | 0.04 |
| PB Ratio | 0.23 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.83.
| Current Ratio | 1.02 |
| Quick Ratio | 0.64 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.15 |
Financial Efficiency
Return on equity (ROE) is -18.43% and return on invested capital (ROIC) is -3.22%.
| Return on Equity (ROE) | -18.43% |
| Return on Assets (ROA) | -2.15% |
| Return on Invested Capital (ROIC) | -3.22% |
| Return on Capital Employed (ROCE) | -9.13% |
| Revenue Per Employee | $147,899 |
| Profits Per Employee | -$24,046 |
| Employee Count | 573 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 0.50 |
Taxes
| Income Tax | -130,486 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +80.04% in the last 52 weeks. The beta is 0.57, so LSB's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +80.04% |
| 50-Day Moving Average | 0.98 |
| 200-Day Moving Average | 1.92 |
| Relative Strength Index (RSI) | 41.78 |
| Average Volume (20 Days) | 92,595 |
Short Selling Information
The latest short interest is 76,590, so 0.19% of the outstanding shares have been sold short.
| Short Interest | 76,590 |
| Short Previous Month | 182,443 |
| Short % of Shares Out | 0.19% |
| Short % of Float | 1.63% |
| Short Ratio (days to cover) | 0.10 |
Income Statement
In the last 12 months, LSB had revenue of $84.75 million and -$13.78 million in losses. Loss per share was -$0.72.
| Revenue | 84.75M |
| Gross Profit | 69.89M |
| Operating Income | -6.83M |
| Pretax Income | n/a |
| Net Income | -13.78M |
| EBITDA | -1.78M |
| EBIT | -6.83M |
| Loss Per Share | -$0.72 |
Full Income StatementBalance Sheet
The company has $3.87 million in cash and $57.11 million in debt, giving a net cash position of -$53.24 million or -$1.29 per share.
| Cash & Cash Equivalents | 3.87M |
| Total Debt | 57.11M |
| Net Cash | -53.24M |
| Net Cash Per Share | -$1.29 |
| Equity (Book Value) | 68.87M |
| Book Value Per Share | 3.32 |
| Working Capital | 2.41M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$16.67 million and capital expenditures -$1.75 million, giving a free cash flow of -$18.63 million.
| Operating Cash Flow | -16.67M |
| Capital Expenditures | -1.75M |
| Free Cash Flow | -18.63M |
| FCF Per Share | -$0.45 |
Full Cash Flow StatementMargins
Gross margin is 82.47%, with operating and profit margins of -8.06% and -16.26%.
| Gross Margin | 82.47% |
| Operating Margin | -8.06% |
| Pretax Margin | -16.41% |
| Profit Margin | -16.26% |
| EBITDA Margin | -2.10% |
| EBIT Margin | -8.06% |
| FCF Margin | n/a |
Dividends & Yields
LSB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -89.95% |
| Shareholder Yield | -89.95% |
| Earnings Yield | -43.65% |
| FCF Yield | -59.03% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 4, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Oct 4, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
LSB has an Altman Z-Score of -1.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.67 |
| Piotroski F-Score | 2 |